Tanshinone IIA increases TRAIL‐induced NSCLC cell death by selectively activating PERK/ATF4 and inhibiting the STAT3‐mediated upregulation of DR5 and downregulation of Survivin.247. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.